Replies to post #526 on Allarity Therapeutics Inc (ALLR)

[georgie18]

ALLR...$1.09...Trying to Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 390871

Wednesday, March 05, 2025 1:44:05 PM

Post#
390872
of 390880
ALLR...$1.02...🥳...Psar flipped Bullish...Hit $1.05 Resistance at the 50ma...Lets see if ALLR can Break/Hold $1.05 and Breakout...

georgie18

Member Level
Re: georgie18 post# 676181

Wednesday, March 05, 2025 12:17:51 PM

Post#
676229
of 676236
ALLR...22,000 share buy @ 9782...🥳

georgie18

Member Level
Re: georgie18 post# 390833

Wednesday, March 05, 2025 9:45:01 AM

Post#
390865
of 390870
ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html